Home LiteratureArticle Details
PMID: 3984656 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Gastric cancer with special reference to prognostic factors. A review of 779 cases.

Acta chirurgica Scandinavica ·Vol. 151 ·No. 1 ·1985-00-00 ·Pages 49-55

Nielsen J, Aagaard J, Toftgaard C

Abstract

A series of 779 patients with gastric cancer diagnosed in the 20-year period 1960-1979 is presented. Surgery was performed in 86% of the cases, but was judged to be radical in only 28%. The operative mortality in the total period was 14.3%, with a fall in the final 5-year period. Patient age, stage of cancer and radicality of operation were prognostic factors as regards survival time. The overall 5-year survival rate was 12%. The rate was 37% after radical surgery, increasing to 49% when corrected for age and sex. The survival rate was unchanged during the period of the study. The crude 5-year survival among the patients with radical surgery was 41% and was independent of the type of surgery. Median age was significantly lower in the patients with early-stage cancer than in the series as a whole. The numbers of younger patients increased during the last ten years of the study.

MeSH Terms
Age Factors Aged Denmark Female Gastrectomy Humans Male Middle Aged Neoplasm Staging Postoperative Complications/mortality Prognosis Retrospective Studies Stomach Neoplasms/mortality,pathology,surgery Time Factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nielsen J
Aagaard J
Toftgaard C
Article Info
Journal
Acta chirurgica Scandinavica
Abbr.
Acta Chir Scand
ISSN
0001-5482
Published
1985-00-00
Pages
49-55
Language
English
Region
Sweden
NLM ID
7906530
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com